Literature DB >> 7523907

The effect of T-lymphocyte 'clonality' on the calculated hprt mutation frequency occurring in vivo in humans.

J P O'Neill1, J A Nicklas, T C Hunter, O B Batson, M Allegretta, M T Falta, R F Branda, R J Albertini.   

Abstract

The frequency of 6-thioguanine resistant (TGr) mutant T-lymphocytes arising in vivo in humans can be quantified with a cell cloning assay. However, the in vivo proliferation of T-lymphocytes that may include TGr mutant cells can distort the relationship between mutation events and the resulting frequency of mutant cells. The T-cell receptor (TCR) gene rearrangement pattern of T-cell colonies can be used as an independent measure of clonality. Analysis of T-cell 'clonality' in 413 wild type and 1736 TGr mutant isolates from 58 individuals shows that mutant clonality is a frequent occurrence (35/58 individuals = 60.3%). However, a major effect on the mutant frequency corrected for clonality (the calculated 'mutation frequency') was found only in nine samples all of which had mutant frequencies greater than 40 x 10(-6).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523907     DOI: 10.1016/0165-1161(94)90052-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Influence of sex, smoking and age on human hprt mutation frequencies and spectra.

Authors:  J Curry; L Karnaoukhova; G C Guenette; B W Glickman
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

2.  X-rays induce distinct patterns of somatic mutation in fetal versus adult hematopoietic cells.

Authors:  Li Liang; Li Deng; Marc S Mendonca; Yanping Chen; Betty Zheng; Peter J Stambrook; Changshun Shao; Jay A Tischfield
Journal:  DNA Repair (Amst)       Date:  2007-06-05

3.  Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients.

Authors:  Mark R Albertini; Michael D Macklin; Cindy L Zuleger; Michael A Newton; Stephen A Judice; Richard J Albertini
Journal:  Environ Mol Mutagen       Date:  2008-12       Impact factor: 3.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.